# Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

> **NCT04766385** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 54 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** KHK7791

## Key facts

- **NCT ID:** NCT04766385
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-03
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766385, "Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04766385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*